RxDoctor Payments Data

Scott Slater, NP

Family · Warren, MINPI 1821625179

Payments from drug & device makers

$4,429in general payments, 2019–2025

Across 242 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Orexo US, Inc.$657
  • Otsuka America Pharmaceutical, Inc.$490
  • Indivior Inc.$458
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$380
  • Lundbeck LLC$314
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$4,429100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,429 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$19,371
Medicare patients
45
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl304$42,636
ZubsolvBuprenorphine Hcl/Naloxone Hcl54$36,172
SuboxoneBuprenorphine Hcl/Naloxone Hcl38$15,996
Lurasidone Hcl13$1,071
Pregabalin22$505
Gabapentin61$432
Ibuprofen30$272
Atorvastatin Calcium18$254
Amlodipine Besylate32$250
Bupropion Hcl SrBupropion Hcl15$230
Lisinopril37$219
Tamsulosin Hcl12$140
Duloxetine Hcl14$136
Trazodone Hcl12$125
Quetiapine Fumarate11$74

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Orexo US, Inc.Zubsolv$657$36,17254 claims
Indivior Inc.Suboxone$458$15,99638 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.

Other family in Warren

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →